280 related articles for article (PubMed ID: 20171406)
1. Effects of oral levamisole as an adjuvant to hepatitis B vaccine in adults with end-stage renal disease: a meta-analysis of controlled clinical trials.
Alavian SM; Tabatabaei SV
Clin Ther; 2010 Jan; 32(1):1-10. PubMed ID: 20171406
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis B virus vaccine in chronic kidney disease: improved immunogenicity by adjuvants? A meta-analysis of randomized trials.
Fabrizi F; Dixit V; Messa P; Martin P
Vaccine; 2012 Mar; 30(13):2295-300. PubMed ID: 22285268
[TBL] [Abstract][Full Text] [Related]
3. The effect of diabetes mellitus on immunological response to hepatitis B virus vaccine in individuals with chronic kidney disease: A meta-analysis of current literature.
Alavian SM; Tabatabaei SV
Vaccine; 2010 May; 28(22):3773-7. PubMed ID: 20371390
[TBL] [Abstract][Full Text] [Related]
4. Effect of levamisole supplementation on hepatitis B virus vaccination response in hemodialysis patients.
Sali S; Alavian SM; Hajarizadeh B
Nephrology (Carlton); 2008 Oct; 13(5):376-9. PubMed ID: 18518938
[TBL] [Abstract][Full Text] [Related]
5. Meta-analysis: intradermal vs. intramuscular vaccination against hepatitis B virus in patients with chronic kidney disease.
Fabrizi F; Dixit V; Magnini M; Elli A; Martin P
Aliment Pharmacol Ther; 2006 Aug; 24(3):497-506. PubMed ID: 16886915
[TBL] [Abstract][Full Text] [Related]
6. Meta-analysis: levamisole improves the immune response to hepatitis B vaccine in dialysis patients.
Fabrizi F; Dixit V; Messa P; Martin P
Aliment Pharmacol Ther; 2010 Sep; 32(6):756-62. PubMed ID: 20662784
[TBL] [Abstract][Full Text] [Related]
7. A randomized clinical trial of immunization with combined hepatitis A and B versus hepatitis B alone for hepatitis B seroprotection in hemodialysis patients.
Tung J; Carlisle E; Smieja M; Kim PT; Lee CH
Am J Kidney Dis; 2010 Oct; 56(4):713-9. PubMed ID: 20630640
[TBL] [Abstract][Full Text] [Related]
8. Levamisole treatment enhances protective antibody response to hepatitis B vaccination in hemodialysis patients.
Kayataş M
Artif Organs; 2002 Jun; 26(6):492-6. PubMed ID: 12072104
[TBL] [Abstract][Full Text] [Related]
9. Adjuvanted hepatitis B vaccine: new drug. Patients with renal failure: similar response rate but fewer boosters needed.
Prescrire Int; 2008 Dec; 17(98):234-6. PubMed ID: 19422145
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis B virus vaccine in lymphoproliferative disorders: a prospective randomized study evaluating the efficacy of granulocyte-macrophage colony stimulating factor as a vaccine adjuvant.
Yağci M; Acar K; Sucak GT; Yamaç K; Haznedar R
Eur J Haematol; 2007 Oct; 79(4):292-6. PubMed ID: 17655695
[TBL] [Abstract][Full Text] [Related]
11. Meta-analysis: the adjuvant role of granulocyte macrophage-colony stimulating factor on immunological response to hepatitis B virus vaccine in end-stage renal disease.
Fabrizi F; Ganeshan SV; Dixit V; Martin P
Aliment Pharmacol Ther; 2006 Sep; 24(5):789-96. PubMed ID: 16918882
[TBL] [Abstract][Full Text] [Related]
12. Improved immunogenicity of a novel third-generation recombinant hepatitis B vaccine in patients with end-stage renal disease.
Weinstein T; Chagnac A; Boaz M; Ori Y; Herman M; Zevin D; Schmilovitz-Weiss H; Gafter U
Nephron Clin Pract; 2004; 97(2):c67-72. PubMed ID: 15218332
[TBL] [Abstract][Full Text] [Related]
13. The safety and efficacy of GM-CSF as an adjuvant in hepatitis B vaccination of chronic hemodialysis patients who have failed primary vaccination.
Evans TG; Schiff M; Graves B; Agosti J; Barritt ML; Garner D; Holley JL
Clin Nephrol; 2000 Aug; 54(2):138-42. PubMed ID: 10968690
[TBL] [Abstract][Full Text] [Related]
14. A randomised controlled trial of intradermal hepatitis B vaccination and augmentation of response with erythropoietin.
Anandh U; Thomas PP; Shastry JC; Jacob CK
J Assoc Physicians India; 2000 Nov; 48(11):1061-3. PubMed ID: 11310381
[TBL] [Abstract][Full Text] [Related]
15. Intradermal vs intramuscular vaccine against hepatitis B infection in dialysis patients: a meta-analysis of randomized trials.
Fabrizi F; Dixit V; Messa P; Martin P
J Viral Hepat; 2011 Oct; 18(10):730-7. PubMed ID: 20819147
[TBL] [Abstract][Full Text] [Related]
16. Benefits and risks of adjunctive inhaled corticosteroids in chronic obstructive pulmonary disease: a meta-analysis.
Sobieraj DM; White CM; Coleman CI
Clin Ther; 2008 Aug; 30(8):1416-25. PubMed ID: 18803985
[TBL] [Abstract][Full Text] [Related]
17. Effect of adding levamisole on seroconversion response to hepatitis B virus vaccination in hemodialysis patients: a single-center experience.
Sanadgol H; Khoshnoodi M; Mashhadi MA; Forghani MS
Iran J Kidney Dis; 2011 Sep; 5(5):338-41. PubMed ID: 21876312
[TBL] [Abstract][Full Text] [Related]
18. Antibody response to hepatitis B vaccine in end-stage renal disease patients.
Chow KM; Law MC; Leung CB; Szeto CC; Li PK
Nephron Clin Pract; 2006; 103(3):c89-93. PubMed ID: 16534237
[TBL] [Abstract][Full Text] [Related]
19. Comparative immunogenicity of 2 recombinant hepatitis B vaccines (GeneVac-B and Engerix-B) in adult patients with chronic renal failure.
Rajapurkar MM; Gang S; Dabhi M; Kulkarni PS
J Nephrol; 2007; 20(5):596-601. PubMed ID: 17918146
[TBL] [Abstract][Full Text] [Related]
20. Antibody response to Engerix-B and Recombivax-HB hepatitis B vaccination in end-stage renal disease.
Lacson E; Teng M; Ong J; Vienneau L; Ofsthun N; Lazarus JM
Hemodial Int; 2005 Oct; 9(4):367-75. PubMed ID: 16219057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
